What are the common causes of cortical thickening of a lymph node?

Cortical Thickening of Lymph Nodes: Common Causes

Cortical thickening of a lymph node occurs primarily due to reactive/inflammatory processes (infection, inflammation, post-vaccination), metastatic malignancy, or lymphoma, with the specific etiology determined by cortical thickness measurement, morphologic features, and clinical context.

Primary Etiologies

Benign/Reactive Causes

Lymph node cortical thickening most commonly represents benign reactive hyperplasia in response to:

• Infection and inflammation - including pneumonia, thoracic infections, and chronic skin wound colonization 1, 2
• Post-vaccination response - particularly after COVID-19 mRNA vaccination, where cortical thickening can persist for 24-28 weeks with mean cortical thickness peaking at weeks 2-7 3
• Chronic inflammatory conditions - congestive heart failure, granulomatous diseases (sarcoidosis), and interstitial lung diseases 2
• Autoimmune/systemic diseases - collagen vascular diseases, extrinsic allergic alveolitis 2

Malignant Causes

Metastatic disease causes cortical thickening through:

• Direct tumor infiltration and nodal capsule violation 1
• Replacement of normal nodal architecture
• Associated features: firm consistency, fixation to adjacent tissues, size >1.5 cm, abnormal fatty hilum 1

Lymphoma produces cortical thickening through:

• Infiltrative lymphoid proliferation
• Often presents with multiple enlarged nodes and systemic symptoms 2

Diagnostic Thresholds and Features

Size Criteria

• Normal threshold: Cortical thickness >3 mm warrants attention 4, 5
• Increased suspicion: ≥4 mm cortical thickness has PPV of 0.67 for malignancy in breast cancer patients 5
• High suspicion: ≥4.25 mm has PPV of 0.74 for metastatic disease 5
• Mediastinal nodes: Short axis >15 mm guides management decisions 2

Morphologic Features Distinguishing Benign from Malignant

Benign characteristics:

• Smooth, well-defined borders
• Uniform homogeneous attenuation
• Preserved central fatty hilum 2
• Diffuse smooth cortical thickening (post-vaccination) 4

Malignant characteristics:

• Loss/effacement of fatty hilum (OR 3.44 for metastasis) 5
• Irregular borders 1
• Necrosis or cystic change 1
• Focal rather than diffuse cortical thickening
• Firm texture, reduced mobility, fixation 1

Clinical Context Matters

Patient Demographics

• Race: Black women have significantly greater normal cortical thickness (mean 3.3 mm) compared to white women (mean 2.6 mm), affecting biopsy thresholds 6
• Age >40 years: Increases malignancy risk, particularly with tobacco/alcohol use 1

Temporal Factors

• Post-vaccination: Cortical thickening within 3 weeks of COVID-19 booster is common (19% incidence), with median presentation at 9 days 7
• Persistent enlargement: Nodes present ≥2 weeks without infectious etiology raise malignancy concern 1

Associated Clinical Features Suggesting Malignancy

• Absence of recent infection 1
• Unexplained weight loss
• Symptoms referable to primary tumor site (dysphagia, otalgia, voice change) 1
• History of prior malignancy 1

Practical Management Algorithm

For cortical thickness 3-4 mm:

• Assess morphology (hilum, borders, enhancement pattern)
• Consider clinical context (recent vaccination, infection, demographics)
• If benign features and explainable cause: observe or short-term follow-up

For cortical thickness ≥4 mm:

• Evaluate for malignant morphologic features
• If suspicious features present: ultrasound-guided FNA 8
• If post-vaccination context: consider 3-month follow-up before biopsy 7

For cortical thickness >15 mm (mediastinal):

• Assess for pulmonary disease, cardiac disease, or systemic conditions
• If unexplained: consider PET/CT or biopsy 2

Critical Pitfalls to Avoid

1. Don't ignore racial differences - applying uniform 3 mm threshold may lead to unnecessary biopsies in Black women 6
2. Don't rush to biopsy post-vaccination nodes - allow 3-4 weeks for resolution, especially if diffuse smooth cortical thickening 4, 3, 7
3. Don't rely on size alone - morphologic features (hilum, borders, necrosis) are equally important 5
4. Don't dismiss nodes in patients with chronic conditions - heart failure and interstitial lung disease commonly cause reactive adenopathy 2